306 related articles for article (PubMed ID: 15739081)
21. [Multivariate survival analysis in patient with laryngeal squamous cell carcinomas].
Guo J; Chen F; Guan Z; Chen Y; Li Q; Ouyang D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):636-9. PubMed ID: 17017186
[TBL] [Abstract][Full Text] [Related]
22. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma.
Li D; Feng J; Wu T; Wang Y; Sun Y; Ren J; Liu M
Am J Pathol; 2013 Jan; 182(1):64-70. PubMed ID: 23141928
[TBL] [Abstract][Full Text] [Related]
23. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
24. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A; Weller P; Kanaan O; Nel I; Heusgen L; Höing B; Haßkamp P; Zander S; Mandapathil M; Dominas N; Arnolds J; Stuck BA; Lang S; Bankfalvi A; Brandau S
BMC Cancer; 2018 Mar; 18(1):272. PubMed ID: 29523110
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic significance of EGFR and p53 expression, and angiogenesis in laryngeal squamous cell carcinoma].
Watanabe H; Suzuki T; Ito Y; Mizuta K; Sawai S; Miyata H
Nihon Jibiinkoka Gakkai Kaiho; 1999 Feb; 102(2):243-53. PubMed ID: 10191626
[TBL] [Abstract][Full Text] [Related]
26. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Liu Y; Li Y; Liu Z; Zhang L; Anniko M; Duan M
Acta Otolaryngol; 2011 Jul; 131(7):769-73. PubMed ID: 21466263
[TBL] [Abstract][Full Text] [Related]
28. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
[TBL] [Abstract][Full Text] [Related]
29. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.
Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C
Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874
[TBL] [Abstract][Full Text] [Related]
30. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
31. Alteration of p53 gene structure and function in laryngeal squamous cell cancer.
Golusinski W; Olofsson J; Szmeja Z; Szyfter K; Szyfter W; Biczysko W; Hemminki K
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S133-7. PubMed ID: 9065648
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
[TBL] [Abstract][Full Text] [Related]
34. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
35. [Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].
Liu Y; Li G; Su ZW; Qiu YZ; Zhang X; Yu CY; Zhou XJ; Ren SL; Huang DH; Tian YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):111-5. PubMed ID: 23710918
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
40. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
Pizem J; Cör A; Gale N
Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]